PUBLIC COMPANY
saveMylan Pharmaceuticals Inc
updated 2mo ago
Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Previously, the company was domiciled in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and a "Global Center" in Canonsburg, Pennsylvania, US.
community read0 votes
🐶 often sniffed alongside
top 8- tagRecall23 co-mentions · 21 sources
- drugEuthyrox19 co-mentions · 19 sources
- drugTirosint19 co-mentions · 19 sources
- drugLevolet19 co-mentions · 19 sources
- drugErmeza19 co-mentions · 19 sources
- drugLevoxyl19 co-mentions · 19 sources
- druglevothyroxine sodium19 co-mentions · 19 sources
- company$VTRSViatris Inc11 co-mentions · 11 sources
pipeline
49
marketed
48
phase 3
0
catalysts ytd
9
approvals ytd
7
recalls ytd
0
Pipeline(49)
view full pipeline →pipeline depth49 products
48Marketed1Unknown
Marketed
(amiloride hydrochloride + hydrochlorothiazide)
Congestive Heart Failure (Heart Failure)
Marketed(amitriptyline + chlordiazepoxide)
Depression
Marketed(amitriptyline hydrochloride + perphenazine)
Anxiety Disorders
Marketed(amlodipine besylate + telmisartan)
Hypertension
Marketed(ampicillin sodium + sulbactam sodium)
Complicated Intra-Abdominal Infections
Marketed(azelastine hydrochloride + fluticasone propionate)
Seasonal Allergic Rhinitis
Marketed(ethinylestradiol + norelgestromin) ER
Female Contraception
Marketed(hydrochlorothiazide + spironolactone)
Hypokalemia
Marketed(lamivudine + tenofovir disoproxil fumarate)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
MarketedAccuneb
Bronchospasm
MarketedAloprim
Hyperuricemia
MarketedAmaluet
Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase3Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential
- phase2Investigating Ovulation Inhibition for Use as a Contraceptive
- —Study to Evaluate the Effectiveness of Legalon®
- phase2Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch
- phase1Steady-State Study of Extended Phenytoin Sodium Capsules 100 mg and Dilantin® Kapseals® 100 mg
- phase1Fasting Study of Anagrelide Hydrochloride Capsules 1 mg to Agrylin® Capsules 1 mg
- phase1Fed Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg
- phase1Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that